Lexie B3 vs Yeasound RIC700
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Lexie B3
The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.
Choice

Yeasound RIC700
The Yeasound RIC700 is a budget-priced OTC hearing aid that delivers A-grade performance in HearAdvisor's lab testing, placing it in the top 14% of the 65 OTC devices we've evaluated. At $399, it offers strong value for consumers seeking quality amplification without prescription-level costs. In our testing, the RIC700 excels at speech clarity in quiet environments, scoring 4.2/5—a strong result that sits 1.41 points above the OTC category average. Speech understanding in noisy settings scores 1.9/5, which is above the category average but remains low in absolute terms, a common limitation across OTC devices. Music streaming quality reaches 2.9/5, nearly a full point above the category average, though still mixed overall. Feedback handling is excellent at 4.6/5. The device does show some limitations. Own-voice comfort scores 2.0/5, falling 0.51 points below the category average—users may notice some occlusion effects when speaking. This behind-the-ear style features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The RIC700 competes well within its price bracket, though shoppers should note that the higher-ranked Yeasound RIC800 and Sony CRE-E10 are available at similar price points with stronger overall scores. For budget-conscious consumers prioritizing speech clarity in quieter listening situations, the RIC700 represents a solid option in the OTC market.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit